Eam Investors, LLC Rapt Therapeutics, Inc. Transaction History

Eam Investors, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$29.5 - $39.5 $1.18 Million - $1.58 Million	-40,000 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$29.86 - $39.47 $1.28 Million - $1.7 Million	-43,026 Reduced 51.82%	40,000 $1.24 Million
Q2 2021 Aug 13, 2021	BUY	$17.99 - $40.02 $1.49 Million - $3.32 Million	83,026 New	83,026 $2.64 Million

8.03M

Ticker RAPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,656,600
Market Cap $856M
Description
RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.